Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Signaling Mechanisms and Vascular Function in Diabetes Mellitus
NCT00761852Phase 3Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- May 1999
- Primary completion
- Oct 2007
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ruboxistaurin in type 1 diabetes mellitus (T1D), type 2 diabetes mellitus (T2DM), sponsored by Brigham and Women's Hospital. Started May 1999; status: completed.
02
Drugs
ruboxistaurin
03
Conditions
type 1 diabetes mellitus (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00761852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00761852.